EGFR and gallbladder cancer: It has been demonstrated that PLEK2 interacts with epidermal growth factor receptor (EGFR) and suppresses EGFR ubiquitination mediated by c-CBL, leading to downstream CCL2 transcriptional overexpression and EMT process activation in gallbladder cancer (Shen et al., 2019).